| INTRODUCTION
Tobacco usage is the leading cause of preventable mortality worldwide. Vaporized inhaled nicotine from combusted tobacco is an efficient delivery system that frequently leads to nicotine dependence (ND) . The lifetime incidence of ND may be as high as 25% and is similar across diverse populations (Breslau, Johnson, Hiripi, & Kessler, 2001) . ND clusters in families and large twin studies indicate that ND has a moderate genetic predisposition, with an estimated heritability between 40% and 70% Vink, Willemsen, & Boomsma, 2005) .
Over the past few decades, many large-scale genome-wide association (GWA) studies and meta-analyses have identified a number of single nucleotide polymorphisms (SNPs) associated with the risk of ND and smoking-related behaviors (Bierut et al., 2007; David et al., 2012; Gelernter et al., 2015; Gizer & Ehlers, 2015; Hancock et al., 2015; Liu et al., 2010; Loukola et al., 2014; Nishizawa et al., 2015; Rice et al., 2012; Thorgeirsson et al., 2008 Thorgeirsson et al., , 2010 Tobacco and Genetics Consortium, 2010; Uhl et al., 2008; Zuo et al., 2013) . Among them, the α3/α5/β4 cholinergic nicotinic receptor subunit gene cluster on chromosome 15 consistently shows the most significant replicable risk effect on ND, smoking cessation, smoking quantity, and other smoking-related traits (Thorgeirsson et al., 2008 (Thorgeirsson et al., , 2010 . In 2015, Gelernter et al. conducted a genome-wide meta-analysis on ND, as measured by the Fagerström Test for ND score.
They found that more GWA signals were identified in African American than in European American samples, highlighting the benefit of analyzing populations with different genetic backgrounds (Gelernter et al., 2015) .
GWA studies can detect common genetic variants (defined as minor allele frequency [MAF] ≥1%). These studies have advanced our understanding of the genetics of ND and smoking-related traits, but the identified variants collectively explain only a small fraction of the total heritability of ND. It has been suggested that common variants, which typically exhibit small effect sizes (e.g., R 2 < 0.005), are unlikely to be identified using the customary GWA significance threshold and the sample size typical in most studies (Manolio et al., 2009) . Genomewide meta-analysis, which is used to aggregate individual studies is expected to improve the statistical power for associations and has been successfully used to identify novel genetic variants not previously discovered by single studies (Cho et al., 2012; David et al., 2012; Liu et al., 2010; Mahajan et al., 2014; Nalls et al., 2014;  Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2014). In addition, in the context of mining existing GWA results, the incorporation of functional data in GWA studies and gene-based analysis has the potential to accelerate the discovery of more functionally relevant genes and could also help to elucidate the biological implications of GWA findings (Ioannidis, Thomas, & Daly, 2009 ). Besides common variants, rare and low-frequency variants that
have not been fully covered in GWA studies could explain, at least in part, the risk for common diseases/traits (Manolio et al., 2009) .
Recently, multiple low-frequency and even rare coding variants have been revealed to be associated with the risk of ND in population-based studies Haller et al., 2012; Olfson et al., 2016; Thorsteinsdottir et al., 2014; Xie et al., 2011; Yang et al., 2015; Zuo et al., 2016) , but the role of rare variants in the risk of ND has not been systematically investigated at the genome-wide level.
In the present study, we sought to identify novel common susceptibility SNPs partially responsible for the risk of ND through genome-wide meta-analysis, and explore their possible mechanisms in the pathogenesis of ND. Genome-wide mixed linear model (MLM)-based association analysis on ND was performed for six studies, with subjects stratified into genetically homogeneous European (EUR) and African (AFR) ancestry subgroups. Meta-analyses were carried out in the EUR, AFR, and trans-population merged cohort, which consisted of 18,082 subjects in total. We explored the regulatory effects of the identified SNPs in human brains through expression quantitative trait locus (eQTL) analysis in the Genotype-Tissue Expression (GTEx) data set, and searched for rare nonsynonymous variants in the implicated genes and several previously identified genes in the whole-genome sequencing data in the UCSF Family Alcoholism study.
| MATERIALS AND METHODS

| UCSF family alcoholism study subjects
The UCSF Family Alcoholism study was designed to identify genetic loci that influence susceptibility to alcohol dependence and related phenotypes. It includes small nuclear families and unrelated subjects, and the majority of study subjects are EUR (Vieten, Seaton, Feiler, & Wilhelmsen, 2004) . A total of 2,154 individuals from 970 families from
December 1995 through January 2003 were enrolled in this study.
The recruitment of subjects has been described previously (Vieten et al., 2004) . Briefly, study probands from the community were recruited through direct mail, press releases, advertisements, and etc.
Their relatives were invited by mail to participate. The diagnosis for ND was determined according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV). The samples in the UCSF Family Alcoholism study were subjected to lowpass whole-genome sequencing. Genotypes were imputed from the low-pass sequencing data as previously described (Bizon et al., 2014) .
Briefly, low-coverage, paired-end read whole-genome sequencing for 1,889 samples was performed on Illumina HiSeq2000 sequencers.
Reads from whole-genome sequencing were aligned using BWA version 0.5.8c (Li & Durbin, 2010) . Linkage disequilibrium (LD)-aware variant calls were calculated in a multistage process that initially creates genotype-likelihood files for single samples using samtoolshybrid, then builds initial haplotypes using BEAGLE (Browning & Browning, 2007) , and then runs Thunder (Li, Sidore, Kang, Boehnke, & Abecasis, 2011) using the BEAGLE haplotypes as input (Bizon et al., 2014) . The mean coverage of the cohort was 4.2X. We applied the following quality control (QC) to the whole-genome sequencing data (MAF ≥ 1%, Hardy-Weinberg equilibrium (HWE) in controls p > 1.00 × 10
) and included 8,893,347 common SNPs in the singlevariant association test. After selection for subjects with diagnostic data and completion of QC steps, 918 subjects were identified as ND cases, and 921 were free of ND (Supplementary Table S1 ).
| Database of genotypes and phenotypes (dbGaP) subjects
We accessed five GWA data sets (SAGE: Study of Addiction: Genetics Australian twins and their families) through dbGaP (Bierut et al., 2010; Bierut, Strickland, Thompson, Afful, & Cottler, 2008; Cornelis et al., 2010; Hinrichs et al., 2006; Shand, Degenhardt, Nelson, & Mattick, 2010; Xie et al., 2011) . The ICGHD data set consisted of three subsets Conditions) that were genotyped using three different arrays. The sample sizes ranged from 469 to 6,695 individuals. All subjects were recruited for genetic studies of substance use disorders. The DSM-IV criteria for ND were used as a measure of ND for all studies. The procedures for data collection for these cohorts were described in detail in dbGaP (Available online at: http://www.ncbi.nlm.nih.gov/gap) and in previous literature (Bierut, Stitzel, et al., 2008; Edenberg, 2002; Gelernter et al., 2007; Lessov et al., 2004) . The cohorts contained data for small families and unrelated individuals. See Table 1 for study characteristics and dbGaP accession numbers.
In order to facilitate the meta-analysis in more specific ancestral populations, we employed principal component analysis (PCA) to identify genetically homogeneous populations (Price et al., 2006) . In each dbGaP data set, all samples were analyzed together with the reference samples from the International HapMap Project (International HapMap Consortium, 2003) . Two subsets of genetically homogeneous subjects, described here as EUR and AFR in each study, were selected using the first two principal components. The PCA plots are shown in Supplementary Figure S1 .
| Genomic imputation
We applied QC filters on each individual dbGaP GWA data set (sex check, mean call rate ≥0.90, MAF ≥ 1%, HWE in controls p > 1.00 × 10
−6
). Then, whole-genome imputation was performed using the IMPUTE version 2 (Howie, Fuchsberger, Stephens, Marchini, & Abecasis, 2012) and the integrated haplotypes of the 1000 Genomes Project Phase III reference panel (October 2014 version) (Auton et al., 2015) . Imputation was carried out in each of the seven dbGaP GWA data sets/subsets individually. We applied QC filters on the postimputed data sets: SNPs with imputation information <30%, MAF < 1%
or HWE p-value in controls <1.00 × 10 −6 were excluded from further analysis. Only bi-allelic autosomal SNPs were analyzed in this study.
| Association and meta-analysis
The single-variant association between each common variant and the risk of ND was measured using a MLM or MLM leaving-onechromosome-out (LOCO)-based association as implemented in GCTA for each dbGaP GWA data set and the UCSF Family Alcoholism study (Yang, Lee, Goddard, & Visscher, 2011; Yang, Zaitlen, Goddard, Visscher, & Price, 2014) . Based on previous reports, the MLM-based association appropriately corrects for population stratification and sample relatedness (Yang et al., 2014) .
We performed an inverse-variance fixed-effect meta-analysis based on the cohort effect sizes and standard errors using METAL, with a Cochran's Q test to assess between-study heterogeneity (Willer, Li, & Abecasis, 2010) . Meta-analysis was performed in the 14,713 EUR, 3,369 AFR, and trans-ancestry merged cohorts (Table 1) .
The meta-analysis for the trans-ancestry cohort aggregated ancestryspecific association result from each study. A p-value of <5.00 × 10
was used as the threshold for genome-wide significance (Panagiotou & Ioannidis, 2012) .
| eQTL analysis
We obtained the genotype and transcript expression data for GTEx from the dbGaP by accession number phs000424.v6.p1 (GTEx 
| Gene-based association test
We implemented a gene-based association analysis through MetaXcan using the summary statistics from the ND meta-analysis in the merged trans-population data set (Barbeira et al., 2016) . Transcript expression-level predictive models in multiple tissues were previously generated in PrediXcan using a subset of genotype and expression data from the GTEx data set. Models for ten brain tissue samples were available, when the current study was conducted (cortex, putamen basal ganglia, caudate basal ganglia, frontal cortex, cerebellum, anterior cortex, hypothalamus, cerebellar hemisphere, hippocampus, and nucleus accumbens basal ganglia) (Gamazon et al., 2015) .
MetaXcan uses established predictive models and accepted association summary statistics as input; it then imputes the transcript expression levels and tests the association between these imputed transcript expression levels and the phenotype (Barbeira et al., 2016) .
The mathematics for the gene-based test has been described previously (Barbeira et al., 2016; Gamazon et al., 2015) . Between 8,530 and 13,570 gene transcripts were predicted with high confidence in the ten predictive models. We used as inputs for
MetaXcan the ND meta-analysis association result in the transpopulation merged cohort for 12,768,612 common SNPs that appeared in at least one single data set. The gene association significance threshold was set at 3.68 × 10 −6 after Bonferroni correction.
| Rare-variant association and gene-based test
We looked for an increased frequency of rare nonsynonymous variants in those genes implicated by the present meta-analysis (CACNA2D3, GABBR1, CHRNB2, PEX2, ADAMTSL1, and GLIS3) and several previously well-known ND susceptibility genes (CHRNA3, CHRNA4, CHRNA5, CHRNB4, DISC1, DLC1, KLHL28, and C14ORF28) Container Toolbox (EPACTS) package version 3.2.6 (Kang et al., 2010) . In addition, we employed the Sequence Kernel Association Test (SKAT) under the framework of the EMMAX model in the EPACTS package to perform the gene-based test (Kang et al., 2010; Wu et al., 2011) . The gene-based test included only nonsynonymous variants (including nonsynonymous, splicing, and stop-gain variants) with allele frequency ≤1% and allele count in the cohort of ≥2. We used a significance threshold of p < 0.05 for single rare-variant association and gene-based tests of the described rare variants.
| RESULTS
We performed a single-variant association analysis of common variation using MLM on each individual dbGaP GWA data set and the UCSF Family Alcoholism study for the EUR and AFR samples. Figures S3 and S4 ). Although this was not an independent replication effort given the overlap of study samples with the previously published reports (Gelernter et al., 2015; Hancock et al., 2015) , this meta-analyses confirmed rs1051730 in the CHRNA5-CHRNA3-CHRNB4 region and nine other recently reported SNPs in five distinct genomic regions associated with ND with nominal association evidence (p < 0.05, Supplementary Table S2) .
3.1 | Meta-analysis in the AFR cohort ) is 5 kb upstream of the GABBR1 gene ( Supplementary Figures S5 and S6 ).
| Meta-analysis in the merged cohort
In the merged EUR and AFR meta-analysis, it was noted that three SNPs in high LD (rs12680810, rs56225501, and rs28534373) located on chromosome 8 achieved moderate association evidence (p < 2.00 × 10
).
An examination of the study specific results indicated more consistent results for the EUR than the AFR samples (Supplementary Table S5 and Figures S5 and S6 ). Among them, the most significant SNP, rs12680810
(OR = 1.03, MAF = 41% and 22% in the EUR and AFR samples, respectively, p = 9.76 × 10
), showed a significant eQTL effect on the , Supplementary Table S5 and Figures S5 and S6 ); both showed a consistent effect on the risk of ND across all individual studies and achieved at least nominal association evidence in both EUR and AFR ancestry-specific meta-analyses (Supplementary Table S5 , Supplementary Figure S7 ).
Finally, SNP rs62392942 achieved significant association and showed identical effect direction in the EUR and AFR samples, although it achieved nominal significance only in the EUR meta-analysis (Supplementary Table S5 and Figure S6 ). SNP rs62392942 resides downstream of the GABBR1 gene on chromosome 6, and is highly correlated with ). The C allele of rs62392942, which was associated with increased risk for ND, exhibited an eQTL effect on GABBR1 gene mRNA in human brain putamen (Supplementary Figure S7) . Using the merged EUR and AFR meta-analysis summary statistics, the GABBR1 gene was significantly associated with risk for ND in the gene-based MetaXcan analysis (p = 6.36 × 10
−7
). Table S6 ). Six heterozygotes subjects were identified with this rare variant and they were all diagnosed with ND. Similarly, although no aggregate effect of rare nonsynonymous variants was discovered in PEX2 or GLIS3 (Table 2) Table S6 ). The remaining genes implicated in the present meta-analysis (GABBR1, CHRNB2, ADAMTS1, and LINC00476) were not supported by the rare variant analysis.
Among genes previously implicated in the etiology of ND, a rare nonsynonymous variant in DLC1 was nominally associated with ND (Supplementary Table S6 ), but the gene-based tests did not identify any significant aggregate associations with ND in previously identified susceptibility genes (CHRNA3, CHRNA4, CHRNA5, CHRNB4, DLC1, DISC1, C14ORF28, and KLHL28) ( Table 2) .
| DISCUSSION
ND has a reported heritability of 40-70% Vink et al., 2005) . Although GWA studies have previously detected multiple loci associated with ND, even in aggregate they only account for a small fraction of the measured heritability of ND.
In the present study, genome-wide meta-analyses were used to identify common SNPs associated with susceptibility for ND. Findings from these meta-analytic efforts were then further explored by using transcriptional expression data in human brains evaluate the possible regulatory effects of the implicated SNPs on gene expression. This study confirmed five previously reported loci (i.e., CHRNA5-A3-B4, KLHL28, C14ORF28, DISC1, and DLC1), identified a novel susceptibility gene CACNA2D3 in the African data set as well as six other potential loci on chromosomes 1, 6, 8, and 9. We provided further evidence suggesting that these implicated SNPs altered mRNA expression levels of genes CACNA2D3, HAX1, CHRNB2, ADAMTSL1, GLS3, LINC00476, and PEX2 through eQTL effects in human brains. Analyses of rare variants conducted in the UCSF Family Alcoholism study provided further evidence for the implicating genes. Specifically, we searched for rare nonsynonymous variants occurring in the implicated genes in low-pass whole-genome sequencing data in the UCSF Family Alcoholism study, and identified four rare nonsynonymous variants in the CACNA2D3, HAX1, PEX2, and GLIS3 genes that conferred risk for ND, as well as an aggregate effect of rare nonsynonymous variants in HAX1 associated with ND diagnostic status. Together, these results demonstrate the utility of meta-analysis, when supplemented with the analysis of expression-level data and sequence-based data, for accelerating the discovery of functionally relevant genes involved in the etiology of ND.
In the present study, a novel genome-wide significant association of rs56247223 on chromosome 3 with risk for ND was identified in the African samples. SNP rs56247223 is located in an intron of CACNA2D3, and was associated with mRNA expression levels of CACNA2D3 in three human brain regions (cortex, frontal cortex, and putamen). In terms of its function, CACNA2D3 encodes a protein member of the voltage-dependent calcium channel complex. Calcium channels mediate the influx of calcium ions into cells and have an important role in neurotransmission (Simms & Zamponi, 2014) .
Calcium channels have been widely implicated in the pathophysiology of substance dependence, and they are therapeutic targets for addiction medications (Addolorato, Leggio, Hopf, Diana, & Bonci, 2012; Zamponi, 2016) . Several different types of calcium channels exist, and each typically consists of four subunits of which the CACNA2D3 gene encodes the alpha-2/delta subunit (Simms & Zamponi, 2014) . Genomic aberrations of the genes encoding the alpha subunit of these channels have been associated with epilepsy and neuropsychiatric disorders such as autism and schizophrenia (Vergult et al., 2015) . This may be important given that smoking behavior is highly prevalent in schizophrenia patients (Dickerson et al., 2013) . Of direct relevance to the present study, the voltagedependent calcium channel complex alpha-2 and delta subunit family member gene CACNA2D1, was previously associated with risk of ND (Gelernter et al., 2015) . With respect to the association of rs56247223
with ND in present study, the protective A allele of rs56247223 was associated with a decreased expression level of the gene CACNA2D3 in human brain. This finding is consistent with the observation that expression of L-type high voltage-gated calcium channel alpha2/delta subunits increases after chronic nicotine administration in mouse brain (Hayashida, Katsura, Torigoe, Tsujimura, & Ohkuma, 2005) . CAC-NA2D3 has also been implicated with other smoking phenotypes, including a robust association with smoking cessation, in a convergent analysis of three GWA data sets (Uhl et al., 2008) . Collectively, these results support CACNA2D3 as a susceptibility gene and potential as a therapeutic target for the treatment of ND.
Despite this evidence, it should be noted that rs56247223 was not significantly associated with ND in the European ancestry cohort.
Differences in genetic background may explain why an association was detected in the African but not in the European populations.
Nonetheless, the detection of a rare nonsynonymous variant in the CACNA2D3 gene confers a large risk (OR > 3) for ND in the UCSF Family Alcoholism study of which the majority of subjects are of European ancestry, provides additional support that the gene plays a role in ND.
We found an association of the SNP rs1760803 with ND in the European ancestry cohorts. The mRNA expression levels of two nearby genes, HAX1 and CHRNB2 in human brain tissue were found to be associated with this SNP. In the UCSF Family Alcoholism study, one rare nonsynonymous variant in HAX1 was associated with an increased risk of ND, and the presence of rare variants in the HAX1 gene was found to be associated with an increased risk of ND diagnostic status. The HAX1 gene encodes a protein that often binds to several proteins, including cortactin and the product of the polycystic kidney disease two gene. Mutations in the HAX1 gene are responsible for autosomal recessive severe congenital neutropenia (SCN) and mutations in the HAX1 protein B isoform are associated with neuropathy in patients with SCN (Boztug et al., 2010) . The nicotine receptor subunit β2 gene CHRNB2, which is also implicated in this region, has been shown to mediate an early physical and psychological response to nicotine (Ehringer et al., 2007 (Ising et al., 2009) . Additionally, systemic administration of FG7142, an anxiogenic drug and/or a pharmacological stressor that modulates GABA receptors, leads to an increase in mRNA for ADAMTSL1 in the cortex and hippocampus of mice (Kurumaji & Nishikawa, 2012; Kurumaji, Ito, Ishii, & Nishikawa, 2008) . More studies will be needed, however exploring how this gene may potentially influence ND.
In the meta-analysis of European and African merged samples, there was a suggestive association found between ND and SNP rs12348139, an intron in gene GLIS3. This result was partially confirmed by the finding of a rare nonsynonymous variant in GLIS3 in the UCSF Family Alcoholism study cohort that conferred a protective effect on ND. The GLIS3 gene is highly expressed in brain (Cruchaga et al., 2013) .
SNP rs12348139 was an eQTL site for the GLIS3 gene in human brain.
The GLIS3 gene encodes a member of the GLI-similar zinc finger protein family, which is a nuclear protein with five C2H2-type zinc finger domains, and is recognized as a repressor and activator of transcription.
The GLIS3 gene has been identified via GWAS with two commonly used biomarkers, cerebrospinal fluid (CSF) tau, and tau phosphorylated at threonine 181 (ptau), for Alzheimer's disease (Cruchaga et al., 2013) , and also the risk of type 2 diabetes (Cho et al., 2012) . Notably, chronic nicotine administration exacerbates tau pathology in a transgenic model of Alzheimer's disease (Oddo et al., 2005) and cigarette smoking is correlated with a higher risk of Alzheimer's disease and type 2 diabetes (Cataldo, Prochaska, & Glantz, 2010; Spijkerman et al., 2014) . Thus, GLIS3 may have a pleiotropic effect on these three disorders that could explain, in part the pathogenesis underlying the clinical link between cigarette smoking, and Alzheimer's disease, and type 2 diabetes. We also identified SNP rs10759883 in a long non-coding RNA LINC00476 on chromosome 9 that was associated with ND. The minor risk allele C of rs10759883 was found to upregulate the expression level of LINC00476 through eQTL effects in multiple human brain regions.
Although the functional relevance of LINC00476 is unclear, recent evidence suggests that non-coding RNAs play an important and dynamic role in transcriptional regulation, epigenetic signaling, stress responses, and plasticity in the nervous system (Sartor et al., 2012) .
Therefore, the role of LINC00476 in ND is worthy of further investigations.
Finally, two SNPs in the GABBR1 gene were found to be suggestively associated with the risk of ND in the meta-analyses for ND is a complex and multi-faceted construct and as a result it has been operationalized in a number of ways (e.g., DSM-IV diagnosis, Fagerström Test ND score). GWAS of these ND phenotypes have been pursued in multiple independent, large-scale cohorts, but few genomic regions have been consistently and mutually validated. The differences in phenotype definition and phenotypic heterogeneity could be partly responsible for that. In the present study, we used the DSM-IV diagnosis of ND, and thus, it is not surprising that we did not observe significant overlap in association signals previously reported in the GWAS of Fagerström Test ND score (Gelernter et al., 2015) . As noted, phenotypic heterogeneity could have also contributed to the lack of overlapping signals. The presence of co-morbid substance use disorders likely represents one such source of heterogeneity. For example, several of the contributing GWA cohorts were selected on other forms of substance use disorder (e.g., alcohol, cocaine dependence). It is likely that the etiologic factors, including genetic influences, that contribute to the development of ND in individuals with multiple substance use disorders differ, at least in part, from those factors that contribute to the development of ND in individuals with just ND. Unfortunately, data on co-occurring substance dependence diagnoses were not available across all study cohorts and thus, could not be studied as covariates or as moderators in the association analysis. Nonetheless, the potential impact of polysubstance use on the observed associations, and results from GWAS of substance use disorders more broadly is an important focus of study that we hope future studies will be able to address.
The findings of this study should be interpreted in light of several limitations. One limitation is that several findings did not exceed the traditional genome-wide significance threshold, however, follow-up analyses such as the eQTL analysis provided some additional support for these findings. The eQTL analyses did not employ genome-wide corrections for multiple testing because they were conducted to address the specific hypothesis that variants in a candidate gene are associated with expression levels when there is prior evidence of association. The second limitation is the lack of an "independent"
validation sample. Recent large-scale genome-wide meta-analyses have implemented broadly a two-stage study design in which they perform the initial meta-analysis, pick a set of variants to carry forward, then pursue replication attempts in sets of independent studies, and finally conduct a combined analysis of all available data.
Because it has been argued that the validation effort in the metaanalysis of a two-stage design is not a true independent replication ) and considering the relatively small sample size in the present study, we pursued a single-stage rather than two-stage design with the aim at gathering exhaustively all available data to improve power for discovery.
In summary, we carried out a large-scale GWA meta-analysis on ND, and identified seven susceptibility signals for ND. Notably, our study provides several lines of evidence supporting key role for genes CACNA2D3 and GABBR1 in ND. The respective proteins of these genes are important for calcium channel and GABA neurotransmitter signaling, both of which are currently the main therapeutic targets for the treatment of ND. These findings not only elucidate the pathophysiology of ND, but also highlight potential therapeutic targets.
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